6-KThe Wire
China SXT Pharmaceuticals, Inc. files 6-K
Filed Jul 6, 2026 · 7d ago · Accession 0001213900-26-075528
Plain English
China SXT Pharmaceuticals Inc. entered into a securities purchase agreement to issue and sell up to $30,000,000 of its Class A ordinary shares to an institutional investor. The initial sale of $3,150,000 is expected to close on July 6, 2026, with proceeds for working capital and corporate purposes.
Filing details
- Ticker
- SXTC
- CIK
- 1723980
- Form type
- 6-K
- Filing date
- Jul 6, 2026
- Report date
- Jul 6, 2026
- Document
- ea0296876-6k_chinasxt.htm
- Size
- 432 KB